期刊文献+

伴有癫痫的人脑胶质瘤中HMGB1/TLR4的表达研究 被引量:13

Expressions of HMGB1 and TLR4 in human glioma tissues of patients combined with epilepsy
原文传递
导出
摘要 目的 研究高迁移率族蛋白B1 (HMGB 1)/Toll样受体4(TLR4)在胶质瘤瘤体及瘤周组织的表达情况,探讨胶质瘤相关性癫痫的发生机制. 方法 收集郑州大学第五附属医院神经外科自2011年6月至2014年6月手术切除的95例胶质瘤标本,其中低级别胶质瘤(WHO Ⅰ~Ⅱ级)55例,高级别胶质瘤(WHOⅢ~Ⅳ)级40例.免疫组化染色、RT-PCR分别检测胶质瘤瘤体、瘤周组织HMGB1及TLR4蛋白和mRNA的表达. 结果 95例胶质瘤患者中,伴癫痫发作34例(35.79%).低级别胶质瘤患者的癫痫发生率(49.09%)高于高级别胶质瘤患者(17.50%),差异有统计学意义(x2=10.057,P=0.002);伴发癫痫胶质瘤瘤周组织中HMGB1、TLR4蛋白表达阳性率和mRNA表达均高于不伴癫痫胶质瘤瘤周组织,差异有统计学意义(P<0.05);伴、不伴癫痫胶质瘤瘤体组织HMGB1、TLR4蛋白和mRNA的表达比较差异均无统计学意义(P>0.05). 结论 瘤周组织中高表达的HMGB1及TLR4可能参与胶质瘤相关性癫痫的发生发展,有可能成为胶质瘤相关性癫痫治疗的新靶点. Objective To investigate the expression of high mobility group protein b 1 (HMGPB1) and toll-like receptors 4 (TLR4) in human glioma tissues of patients with epilepsy and explore the mechanism of glioma-associated epilepsy.Methods Ninety-five glioma specimens,collected during the resection surgery in our hospital firom June 2011 to June 2014,were used in our experiment;among them,55 were low-grade gliomas and 40 were high-grade gliomas.Immunohistochemistry and real time-PCR were used to assay the protein and mRNA expressions of HMGB1 and TLR4 in glioma tissues and peritumoral tissues,and the relation between HMGB1/TLR4 and glioma-associated epilepsy was analyzed.Results The incidence of glioma-associated epilepsy was 35.79% (34/95),and the incidence of glioma-associated epilepsy in low-grade gliomas (49.09%) was significantly higher than that in high-grade gliomas (17.50%)(x2=10.057,P=0.002).Immunohistochemisty and RT-PCR showed that the protein and mRNA expressions of HMGB1/TLR4 in the peritumoral tissues with glioma-associated epilepsy were significantly higher than those in the peritumoral tissues without glioma-associated epilepsy (P〈0.05),while no significant difference was noted between glioma tissues with and without epilepsy (P〉0.05).Conclusion Over-expression of HMGB1 and TLR4 in peritumoral tissues of glioma patients may be related with the development of glioma-associated epilepsy,which may be a new target in glioma therapy.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2015年第6期563-566,共4页 Chinese Journal of Neuromedicine
基金 河南省教育厅科学技术研究重点项目(14A320078)
关键词 癫痫 神经胶质瘤 高迁移率族蛋白B1 TOLL样受体4 Epilepsy Glioma HMGB1 TLR4
  • 相关文献

参考文献15

  • 1Zentner J, Hufnagel A, Wolf HK, et al. Surgical treatment of neoplasms associated with medically intractable epilepsy [J]. Neurosurgery, 1997, 41(2): 378-387.
  • 2Maroso M, Balosso S, Ravizza T, et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures[J]. Nat Med, 2010, 16(4): 413-419.
  • 3胡杨武,谭启富.药物难治性癫痫手术治疗[J].实用医学杂志,2014,30(6):860-861. 被引量:7
  • 4Harris HE, Andersson U, Pisetsky DS. HMGBI: a multifunctional alarmin driving autoimmune and inflammatory disease[J]. Nat Rev Rheumatol, 2012, 8(4): 195-202.
  • 5Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection [J]. Annu Rev Immtmol, 2011, 29: 139-162.
  • 6Harris HE, Andersson U, Pisetsky DS. HMGB 1: a multifunctional alarmin driving autoimmune and inflammatory disease[J]. Nat Rev Rheumatol, 2012, 8(4): 195-202.
  • 7Leavy O. Cell migration: HMGBl-mediated inflamrlaatory cell recruitment[J]. Nat Rev Immunol, 2012, 12(4): 232-232.
  • 8Zhao M, Zhou A, Xu L, et al. The role of TLR4-mediated PTEN/PI3K/AKT/NF-KB signaling pathway in in hippocampal neurons[J]. Neuroscience, 2014, 269: 93-101.
  • 9Lucas K, Maes M. Role of the toll like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway[J]. Mol Neurobiol, 2013, 48(1): 190-204.
  • 10Wang YC, Wang PF, Fang H, et al. Toll-Like Receptor 4 Antagonist Attenuates Intracerebral Hemorrhage-Induced Brain Injury[J]. Stroke, 2013, 44(9): 2545-2552.

二级参考文献16

  • 1Takeda K, Kaisho T, Akira S. Toll-like receptors [J]. Ann Rev Immunol, 2003, 21(4) :335-376.
  • 2Alexopoulou L, Holt A C, Medzhitov R, et al. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3 [J]. Nature, 2001,413 (6857) :732-738.
  • 3Schmausser B, Andrulis M, Endrich S, et al. Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori [J]. Int J Med Microbiol, 2005, 295 (3):179-185.
  • 4Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA [J]. Nature, 2000, 408 (6813):740- 745.
  • 5Li L. Regulation of innate immunity signaling and its connection with human diseases [J]. Curr Drug Targets Inflamm Allergy, 2004, 3 (1):81-86.
  • 6Barton G M, Medzhitov R. Toll-like receptors and their ligands [J]. Curr Top Microbiol Immunol, 2002, 270: 81-92.
  • 7Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family [J]. Immunol Lett, 2003, 85 (2) :85-95.
  • 8Droemann D, Albrecht D, Gerdes J, et al. Human lung cancer cells express functionally active Toll-like receptor 9 [J]. Resp Res, 2005, 6 (1): 1-10.
  • 9Diamond G, Legarda D, Ryan L K. The innate immune response of the respiratory epithelium [J]. Immunol Rev, 2000, 173 ( 1 ) : 27- 38.
  • 10Medzhitov R. Toll-like receptors and innate immunity [J]. Nat Rev Immunology,2001, 1 (2) : 135-145.

共引文献18

同被引文献96

  • 1Ge WP, Jia JM. Local production of astrocytes in the cerebral cortex [J]. Neuroscience, 2016, 323: 3-9.
  • 2Dong Y, Benveniste EN. Immune fimction of astrocytes [J]. Glia, 2001, 36(2): 180-190.
  • 3Martin R, Bajo-Graneras R, Moratalla R, et al. Circuit-specific signaling in astrocyte-neuron networks in basal ganglia pathways [J]. Science, 2015, 349(6249): 730-734.
  • 4Ebrahimi M, Yamamoto Y, Sharifi K, et al. Astrocyte-expressed FABP7 regulates dendritic morphology and excitatory synaptic function of cortical neurons[J]. Glia, 2016, 64(1): 48-62.
  • 5Rasband MN. Glial contributions to neural function and disease [J]. Mol Cell Proteomics, 2016, 15(2): 355-361.
  • 6Cirillo C, Capoccia E, Iuvone T, et al. S 100B inhibitor pentamidine attenuates reactive gliosis and reduces neuronal loss in a mouse modelofAlzheimer's disease [J]. Biomed Res Int, 2015, 2015: 508342.
  • 7Tung A. New anesthesia techniques[J]. Thorac Surg Clin, 2005, 15 (1): 27-38.
  • 8Gerresheim G, Schwemmer U. [Dexmedetomidine]. Anaesthesist, 2013, 62(8): 661-674.
  • 9Tasdogan M, Memis D, Sut N, et a|. Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis [J]. J Clin Anesth, 2009, 21 (6): 394-400.
  • 10Sonkoly E, Stahle M, Pivarcsi A. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation[J]. Semin Cancer Biol, 2008, 18(2): 131-140.

引证文献13

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部